Skip to main content

Empery Asset Management, LP

SEC CIK
0001469336
Latest filing
Aug 11, 2026

REVBW holding history

Revelation Biosciences, Inc. in every 13F filed by Empery Asset Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REVBW overviewAll 13F holders of REVBWFull Q2 2026 holdings

Shares (Q3 2022)
233,382
Value
$10.0K
% of portfolio
0.1%
Quarters held
3
Since Q1 2022
Holdings of REVBW by Empery Asset Management, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2022––––Not filedHolders
Q3 2022233,382$10.0K0.1%00.0%UnchangedHolders
Q2 2022233,382$19.0K0.1%00.0%UnchangedHolders
Q1 2022233,382$30.0K0.1%+233,382NewHolders